Stock BCACU XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Xynomic Pharmaceuticals Holdings, Inc. Nasdaq

Equities

BCACU

VGG1142P1201

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Xynomic Pharmaceuticals Holdings, Inc. -.--% -19.05%
2021 Xu-Nuo Pharma, Inc. acquired the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc.. CI
2020 Xynomic Pharmaceuticals Holdings, Inc. Announces Resignation of Richard Peidong Wu as Independent Director and the Chairman of the Audit Committee CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BROOKLINE CAPITAL ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Apexigen to Participate in the Brookline Capital Markets Newport Symposium
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Apexigen Appoints William Duke as Chief Financial Officer
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K/A)
AQ
BROOKLINE CAPITAL ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
Xynomic Pharmaceuticals : BROOKLINE CAPITAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Xu-Nuo Pharma, Inc. acquired the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc..
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XYN Stock
  4. BCACU Stock
  5. News Xynomic Pharmaceuticals Holdings, Inc.